A source familiar with the Biogenesis investigation tells HardballTalk that Major League Baseball plans to interview all of the players implicated in the Biogenesis scandal by the end of June. Then, at that point, it will make a decision on whether to pursue discipline and how. The plan is for discipline to be leveled — if it is, indeed, leveled — by the first week of July. Pursuant to the Joint Drug Agreement players will then have the right to appeal if discipline is imposed.
This information confirms ESPN’s Outside the Lines report from last night that Major League Baseball’s investigation of Biogenesis is proceeding. However, any speculation that Major League Baseball has already decided to discipline the players implicated in the Biogenesis scandal or that it has already decided to impose any specific penalties, be they 50- or 100-game suspensions, was premature. The league’s investigation is being assisted by clinic founder Tony Bosch, the source confirmed.
When contacted by HardballTalk, Major League Baseball officials did not comment on the story.
Alex Rodriguez of the New York Yankees, 2011 NL MVP Ryan Braun of the Milwaukee Brewers and Melky Cabrera of the Toronto Blue Jays – who received a 50-game suspension last season for the use of PEDs – are among the 20 players reportedly being targeted by MLB.
Braun issued a stern denial this morning, while Cabrera told USA Today Sports: “I don’t know anything about it. This is the first I hear of it. If they suspend me again, I think that would be a harsh punishment because I already served my sentence. But it’s up to them.”
Rodriguez, once considered a threat to break the sport’s all-time home run record, admitted to ESPN four years ago that he used performance-enhancing drugs earlier in his career, when he played for the Texas Rangers.
Multiple reports circulated in the past week that the Red Sox would need to unload the money truck in order to sign David Price. Well, the truck just got unloaded: Pete Abraham of the Boston Globe reports that the Red Sox have signed David Price to a seven-year, $217 million contract.
This is, by far, the largest free agent contract the Red Sox have ever given a pitcher. It beats Max Scherzer‘s seven-year, $210 million deal signed last offseason as the largest ever free agent pitcher contract. Clayton Kershaw‘s contract extension with the Dodgers was for $215 million.
Price went 82-47 with a 3.18 ERA pitching in the AL East while with the Tampa Bay Rays. After being traded to the Tigers just before the 2014 trade deadline he went 13-8 with a 2.90 ERA in 32 starts. He returned to the AL East with the Blue Jays this year, going 9-1 with a 2.30 ERA in 11 starts. He also pitched in the playoffs for the Jays starting three times in four overall appearances.
The Red Sox were in dire need of pitching and they were said to be gunning for Price to fill that need. Target: acquired.
MLB and the MLBPA just released the annual public report from the Joint Drug Prevention and Treatment Program’s Independent Program Administrator. It’s the annual report, mandated by the JDA, which says how many positive drug tests there were, what the drugs were, etc.
The notable numbers, which cover the period starting when the 2014 World Series ended until the 2015 World Series ended:
- Total number of tests administered: 8,158. 6,536 of them were urine tests, 1,622 of them were blood tests for HGH;
- 10 tests resulted in positives which led to discipline: 7 for PEDs, 2 for stimulants, one for DHEA;
- The previous year there were 7,929 total tests with 12 which resulted in discipline;
- There were the same number of Therapeutic Use Exemptions granted this year as last: 113. All but two were for attention deficit disorder. One was for gynecomastia, which is the swelling of the breast tissue in men due to a hormone imbalance, one was for a stress fracture in someone’s elbow.
A use exemption line item which had appeared on the list for the previous several years — hypogonadism — was not there, so congratulations to the anonymous player who was either cured or who retired.
As we always note, the number of players who got exemptions for ADD drugs is a bit higher than the occurrence of ADD in the population at large and, once you eliminate kids from ADHD occurrences, it’s likely considerably higher. But that’s none of my business.
Only seven hitters in the American League got enough plate appearances while primarily serving time as DH to qualify for the batting title in 2015. And of those some of them — most notably Edwin Encarnacion — played a fair bit of defense, meaning that there weren’t too many guys who could really be called true DHs in the game. Still they give out an award for being the best DH, you only need 100 plate appearances as a DH to be eligible and Kendrys Morales just won it:
Morales received 50 of the 88 first-place votes cast to garner the honor for the first time in his nine-year career . . . Boston’s David Ortiz, a seven-time winner of the ODH Award, finished second with 34 second-place votes after batting .267 (132-for-495) with 35 doubles, 32 homers and 99 RBI in 134 games as DH for the Red Sox this past season . . . Kendrys batted .295 (156-for-529) with 39 doubles, 21 home runs, 104 RBI and 78 runs scored in 141 games as DH for the Royals.
Defense — which for this award has to be thought of as a demerit, right? — couldn’t have separated these two as they both slummed it at first base for nine games. Overall I’d rather have had Ortiz, who walked more, hit for greater power and, batting average notwithstanding, got on base at almost exactly the same clip as Morales did. Similar arguments could be made for A-Rod and Prince Fielder, but no one asks me about such things. They do ask club beat writers, broadcasters and AL public relations departments, however, who vote on the award.
It’s an award that has been around a while — this was the 42nd year for it — but it’s just been known as the Edgar Martinez Award since 2004. It would’ve been really weird if it had been called that in 1978. Martinez was just 15 then.
With a week remaining in their exclusive negotiating window to sign Byung-ho Park the Twins have agreed to a deal with the Korean slugger. Ken Rosenthal of FOXSports.com reports that it’s a four-year, $12 million contract, on top of which the Twins will pay Park’s old team a $12.85 million posting fee for those negotiating rights.
Four years and a total commitment of $24.85 million is certainly a sizable investment, but it’s significantly less than most projections had the Twins spending to get Park under contract.
Last offseason the Pirates bid $5 million to negotiate with Korean shortstop Jung Ho Kang and then signed him to a four-year, $11 million deal. His success in MLB raised the level of interest in Park, who posted similarly spectacular numbers in Korean, but in the end the price tag wasn’t significantly higher. Based on reports from Korea, it sounds like the Twins low-balled him in negotiations and Park basically just accepted it because he wants to play in MLB.
Three weeks ago I wrote a lengthy breakdown of how Park could fit into the Twins’ plans when they secured the high bid, but the short version is that he’ll slot into the lineup as the starting designated hitter and look to prove that his exceptional production in Korean can carry over to MLB. Park hit .343 with 53 homers, 146 RBIs, and a 1.150 OPS in 140 games for Nexen this past season and has topped a 1.000 OPS in each of the past three years.